NASDAQ:CUTR - Cutera Stock Price, Forecast & News

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera, Inc. (NASDAQ:CUTR) announced its quarterly earnings results on Thursday, November, 7th. The medical device company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.23. The medical device company earned $46.12 million during the quarter, compared to analyst estimates of $41.66 million. Cutera had a negative return on equity of 84.67% and a negative net margin of 20.84%. The firm's revenue was up 13.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.11 earnings per share. View Cutera's Earnings History.

Cutera is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Cutera.

Cutera issued an update on its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $180.9-181.9 million, compared to the consensus revenue estimate of $178.96 million.

3 analysts have issued 1-year target prices for Cutera's stock. Their forecasts range from $45.00 to $45.00. On average, they expect Cutera's stock price to reach $45.00 in the next twelve months. This suggests a possible upside of 56.0% from the stock's current price. View Analyst Price Targets for Cutera.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cutera.

Headlines about CUTR stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cutera earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Cutera.

Some companies that are related to Cutera include InMode (INMD), Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Stereotaxis (STXS), Zynex (ZYXI), Semler Scientific (SMLR), Viewray (VRAY), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Soleno Therapeutics (SLNO), Fonar (FONR), Edap Tms (EDAP), BioSig Technologies (BSGM) and Second Sight Medical Products (EYES).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include AbbVie (ABBV), Micron Technology (MU), Alibaba Group (BABA), Pfizer (PFE), Gilead Sciences (GILD), NVIDIA (NVDA), Roku (ROKU), AT&T (T), Biogen (BIIB) and Clovis Oncology (CLVS).

Cutera's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (1.05%), California Public Employees Retirement System (0.33%), Wedge Capital Management L L P NC (0.18%), New York State Teachers Retirement System (0.15%), Strs Ohio (0.13%) and Arizona State Retirement System (0.07%). Company insiders that own Cutera stock include David A Gollnick, Gregory A Barrett, J Daniel Plants, James A Reinstein and Larry Laber. View Institutional Ownership Trends for Cutera.

CUTR stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Arizona State Retirement System, California Public Employees Retirement System and Strs Ohio. View Insider Buying and Selling for Cutera.

CUTR stock was purchased by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Zurcher Kantonalbank Zurich Cantonalbank and New York State Teachers Retirement System. Company insiders that have bought Cutera stock in the last two years include Gregory A Barrett, J Daniel Plants and James A Reinstein. View Insider Buying and Selling for Cutera.

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CUTR stock can currently be purchased for approximately $28.84.

Cutera has a market capitalization of $410.48 million and generates $162.72 million in revenue each year. The medical device company earns $-30,770,000.00 in net income (profit) each year or ($2.23) on an earnings per share basis. Cutera employs 402 workers across the globe.View Additional Information About Cutera.

The official website for Cutera is http://www.cutera.com/.

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]